ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 684

Subchondral Bone Sclerosis on Computed Tomography – Does It Have Any Value in the Diagnosis of Inflammatory Sacroiliitis or Is It a Non-Specific Finding?

Omar Azmat1, Robert G. Lambert2, Zaid Jibri3 and Walter Maksymowych4, 1Diagnostic Imaging, University of Alberta, Edmonton, AB, Canada, 2Radiology, University of Alberta, Edmonton, AB, Canada, 3Diagnostic Imaging, The Ottawa Hospital, Ottawa, ON, Canada, 4Medicine, University of Alberta, Edmonton, AB, Canada

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Computed tomography (CT), spondylarthropathy and subchondral bone

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 13, 2016

Title: Spondylarthropathies and Psoriatic Arthritis – Clinical Aspects and Treatment - Poster I: Axial and Peripheral Spondyloarthritis – Clinical Aspects, Imaging and Treatment

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

 

 

   

Background/Purpose: Sclerosis in the sacroiliac joints (SIJ) on radiography and computed tomography (CT) is common but widely considered a non-specific finding of sacroiliitis due to an association with degeneration and osteitis condensans ilii, despite little formal study. Availability of low dose radiation (CT) may lead to more widespread use for diagnostic evaluation. We standardized the definition of sclerosis on CT and then aimed to determine whether this lesion could be reliably detected and its diagnostic utility. 

 

Methods:

 
215 CT scans were obtained from patients with a history of low back pain. 107 patients had a clinical diagnosis of spondyloarthritis (SpA) and 108 patients were clinically proven not to have SpA. Both groups were age and gender matched (140 males, 75 females). The mean age was 45 years. Three musculoskeletal radiologists, blinded to patient demographics and diagnosis, scored the CTs after standardization of lesion definitions and calibration. Erosions, sclerosis, and ankylosis were graded by size and number of articular surfaces/ joints involved. Sclerosis was considered definite if located along the cartilaginous compartment, measured >5mm in all 3 planes, and present >5mm from the joint surface. Discrepant scores were arbitrated and inter-reader reliability calculated by intra-class correlation coefficient (ICC). Diagnostic utility of CT lesions was determined by calculating sensitivity and specificity for the clinical diagnosis and by logistic regression.  
   

Results:

 
Inter-observer reliability for scoring sclerosis for each articular surface ranged from 0.65-0.76, 0.71-0.78 for erosion, and 0.87-0.95_ for ankylosis. Sclerosis occurred in 87(81%) cases with SpA and 25 (23%) controls. For a single articular surface the specificity for sacroiliitis ranged between 88-94%, and for any two articular surfaces 95-100%. If all 4 articular surfaces were affected, specificity was 100%. Sensitivity ranged from 14% (4 articular surfaces) to 55% (either ilium). Erosion and ankylosis had a similar specificity range of 91-100% and 92–93%, respectively depending on number of joint surfaces involved. The odds ratio was 4.9 for absence/presence of sclerosis, increasing to 12.55 where there was bilateral joint involvement. For erosion the odds ratio increased to 84.2 for bilateral disease and 22.79 for bilateral ankylosis.

 
 
Table demonstrating the specificities and sensitivities with 95%CI of subchondral sclerosis, erosion, and ankylosis.

Conclusion:

 
When sclerosis measures > 5mm in three planes and is located > 5mm from a joint perimeter, it has high specificity for sacroiliitis, regardless of how many articular surfaces are involved, with similar specificity to erosion.  
 

 


Disclosure: O. Azmat, None; R. G. Lambert, None; Z. Jibri, None; W. Maksymowych, AbbVie, Janssen, Pfizer, 2,AbbVie, Amgen, UCB, Pfizer, Merck, Janssen, Eli Lilly, Celgene, Sanofi, Boehringer Ingelheim, Novartis, 5.

To cite this abstract in AMA style:

Azmat O, Lambert RG, Jibri Z, Maksymowych W. Subchondral Bone Sclerosis on Computed Tomography – Does It Have Any Value in the Diagnosis of Inflammatory Sacroiliitis or Is It a Non-Specific Finding? [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/subchondral-bone-sclerosis-on-computed-tomography-does-it-have-any-value-in-the-diagnosis-of-inflammatory-sacroiliitis-or-is-it-a-non-specific-finding/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/subchondral-bone-sclerosis-on-computed-tomography-does-it-have-any-value-in-the-diagnosis-of-inflammatory-sacroiliitis-or-is-it-a-non-specific-finding/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology